Objective: To investigate the risk of clinical affective disorders of patients who were hospitalized because of obesity in the study period 1 January 1977 to 31 December 1999. Method: Using data from Danish hospital registers, three study cohorts were identified by their diagnoses at discharge from hospital: one cohort comprising all patients with a first hospital admission with an index diagnosis of obesity, and two control cohorts comprising all patients with a first hospital admission with an index diagnosis of osteoarthritis or of non-toxic goiter, respectively. Later admissions to psychiatric hospital wards with discharge diagnoses of affective disorders were used as outcome events. Rates of readmission were estimated using competing risks models in survival analyses. Age, sex, abuse, and calendar time were included as covariables in the analyses. Results: A study sample of 165 425 patients discharged with an index diagnosis was identified. In total, 1081 events occurred in the observation period. An index diagnosis of obesity was associated with an increased risk of affective-disorders hospitalization when compared with patients with osteoarthritis (Rate ratio: 1.35 (95% CI: 1.09-1.67)) and tended to be associated with an increased risk when compared to patients with non-toxic goiter (Rate ratio: 1.23 (95% CI: 0.99-1.53)). Patients with obesity diagnoses who did not have additional hospital diagnoses of substance-or alcohol abuse had a risk of affective disorders that was 1.55 (95% CI: 1.23-1.95) times greater than that of osteoarthritis patients without abuse diagnoses. Conclusions: Patients hospitalized with obesity may be prone to developing affective disorders that require in-hospital treatment, but the excess risk is modest. Severe obesity seems to be associated with other risk factors for mood disorders than those related to comorbid alcohol-or substance abuse.
Introduction
Patients with depressive disorder or bipolar disorder are at increased risk of long-lasting functional impairment, and mood disorders are associated with increased mortality. [1] [2] [3] The global prevalence of severe obesity will probably rise markedly. 4, 5 Therefore, the study of comorbid mood disorders in patients treated for obesity is important. In a comprehensive review of the covariations of mood disorders and obesity, McElroy et al. 6 found numerous studies that assessed various aspects of mood pathology in obese persons seeking weight-loss treatment. Most studies estimated present mood symptoms, or retrospectively estimated the lifetime risk of mood disorders. Rates of mood disorders reported ranged from 8 to 60%. However, as the authors of the review pointed out, most of the studies that assessed syndromal mood disorders did not use control groups and this could have caused overestimations of risks owing to Berksons bias. 7 This bias arises because patients with severe obesity are probably seen more often by doctors than non-patients are, and thereby the probability of getting diagnosed with another disease, such as a mood disorder, is increased for the patients. Only two studies combined normal weight controls or general medical controls and operationalized diagnostic criteria for affective symptoms. Both these studies found substantially increased rates of mood disorders in clinical study groups of severely obese patients. 8, 9 However, as both studies recruited control persons from non-clinical settings, a general effect of the treatment-seeking behavior of obese patients may have influenced the findings. Interventional studies have prospectively followed mood changes or changes in personality traits of patients treated for obesity. [10] [11] [12] [13] However, many of these studies were conducted without control patients, and few studies had a follow-up time of more than 2 years. Therefore, we found it relevant to investigate the longterm risk of developing mood disorder in a clinical cohort of patients with obesity with an approach that enabled us to follow many patients over a lengthy period.
Using data available in the Danish patient registers, we conducted a historical prospective cohort study with delayed entry into cohorts. We compared the risks for patients with a hospital diagnosis of obesity, osteoarthritis or non-toxic goiter of receiving diagnoses of affective disorders on readmission to hospital. Our hypothesis was that patients hospitalized with obesity would have higher risks of mood disorders, and hence higher risks of hospitalization with diagnoses of depressive disorder or bipolar disorder, than control patients. We used control patients who had been hospitalized in order to reduce the effect of Berksons bias.
Methods

Data from Danish hospital registers
We obtained data from three Danish registers after approval from the Danish Data Protection Agency.
In Denmark, hospital admissions to psychiatric wards have been recorded in a nationwide register, the Danish Psychiatric Central Research Register (DPCRR) 14 since 1 April 1970.
In the period from 1 April 1970 to 31 December 1993, the Danish edition of the International Classification of Diseases 8 (ICD-8) was used for registration. 15 Since 1 January 1994 the updated International Classification of Diseases 10, ICD-10, has been in use. 16 The admissions to somatic hospital wards have been registered in the Danish National Hospital Register (DNHR) since 1 January 1977, 17 where the ICD-8 and ICD-10 systems have been used in the same manner as in the DPCRR. These public registers are comprehensive of all Danish hospital admissions, as hospital's report of admission data is mandatory. Deaths in Denmark, in hospitals or elsewhere, are all registered in the Danish Register of Causes of Death (DRCD). 18 All Danish citizens have a unique personal identification number that can be logically checked for errors, and this number is used to identify the individual citizen in the various registers. Therefore, data on hospital admissions and deaths can be precisely registered irrespective of changes in the name or address. The rate of migration from Denmark is low, and citizens' use of foreign hospitals is negligible. Thus, the full pattern of hospital admissions in Denmark can be established with confidence.
The hospital registers contain information about the diagnoses of patients, the admission and discharge dates, and the hospital wards where the patients were admitted. There is no detailed data to further describe the status or prognosis of the individual patient. Information about patient characteristics, such as anthropometrical measures including body mass index (BMI), modes of treatment, socioeconomic data, or depression scores, is not available for analysis.
The study sample Three study cohorts were identified as all in-patients with a main diagnosis of obesity (exposed), non-toxic goiter (unexposed), or osteoarthritis (unexposed) at discharge after a first hospital admission (index hospitalization) in the period from 1 January 1977 to 31 December 1999. Obesity was defined by the ICD-8 code 277.99, and the ICD-10 codes E65.0-E66.9. Non-toxic goiter was defined by the ICD-8 codes 240.00-241.99, and the ICD-10 codes E04.0-E04.9. Osteoarthritis was defined by the ICD-8 codes 713.00-713.09, and the ICD-10 codes M15.0-M19.9.
The outcome events were admissions to psychiatric hospitals with main discharge diagnoses of affective disorders as registered in the DPCRR. Affective disorders was defined as either depressive disorder, ICD-8 codes 296.09, 296.29, 286.89, 296.99, and ICD-10 codes F32.0-F33.31, F34.0-F34.9, F38.1-F39.9, or bipolar disorder, ICD-8 codes 296.19, 296.39 and ICD 10 codes F30.0-F31.6, F38.0.
Only main diagnoses were used as index-or eventdiagnoses, as these were posted or supervized by consultants at the various wards discharging the patients. A main diagnosis denotes that investigating or treating this condition is the primary cause of hospitalization.
The data in the registers was collected mainly for administrative purposes. Therefore, the diagnoses in the study were not standardized for research purposes, but were based on reliance on the diagnostic practice of Danish clinicians. The diagnostic validity of the DPCRR-diagnoses has been compared with ICD-10 research criteria for affective disorders and found to be correct in 84% of cases. 19 The validity of the diagnoses in the DHNR ranges from 75 to 90%. 20 To achieve maximum validity, the diagnoses were grouped into syndromal categories, such as 'obesity' or 'depressive disorder', as these could be defined using the first three digits of the ICD diagnoses.
Only incident patients were included in the analyses. Patients admitted to hospital at an age younger than 15 years, and patients registered with a diagnosis of affective disorder or of schizophrenia before the index admission, were excluded. Patients with a first-discharge auxiliary diagnosis of affective disorder, schizophrenia (ICD-8 code 295.xx and ICD-10 code F20-F29), or a diagnosis of one of the other cohorts were excluded. Patients registered in the 
Statistical analysis
The cohort of obesity patients was compared with the nontoxic goiter and the osteoarthritis cohorts using Poisson regression analysis, with affective disorders as the outcome events. As death was expected to be a major hazard for the patients entering the study, affective disorder and death were both treated as outcomes in a competing risks model. Using estimated incidence rates of affective disorders and rates of death, the probability of receiving a subsequent diagnosis of affective disorder was calculated for individuals who were alive and without affective disorder at a given age. When estimating the rate of affective disorders, patients were censored (i.e. excluded from further participation in the study from this point of time) at the time of admission with schizophrenia, at the time of admission with one of the control cohort diagnoses, or at the time of death as registered in the DRCD. If none of these events occurred, patients were censored at the end of the study.
When estimating the rate of death, patients were censored at the time of admission with an affective disorder, schizophrenia, one of the control cohort diagnoses, or at the end of study.
Sex was included in the model as a fixed covariate. Age (divided into groups: 15-25; 25-35; y 85-95; 95 þ years), time after index discharge (0-0.5; 0.5-1; 1 þ years), and calendar period (1977-1982, 1983-1988, 1989-1993, 1994-1999) were all included as time-dependent covariates. Alcohol abuse is associated with binge eating, 22 and may be associated with obesity. 23 Alcohol-and substance abuse is also associated with an increased risk of affective disorders.
To estimate whether an effect of obesity was mediated through disorders of abuse, substance abuse and alcohol abuse were merged into one abuse variable that was included as a time-dependent covariate. Patients were considered as having abuse from the time of first discharge with an abuse main diagnosis (ICD-8 codes 291.09-291.99, 303.09-303.99, 304.09-304.99 and ICD-10 codes DF10.0-DF16.9, DF18.0-DF19.9). Using estimated rates, approximations of the probabilities of receiving a diagnosis of affective disorder were made separately for men and women who were alive, without prior affective disorder diagnoses and without diagnoses of abuse at a given age.
Results
The study sample included 165 425 patients: 11 635 (7.0%) with obesity, 119 743 (72.4%) with osteoarthritis and 34 047 (20.6%) with non-toxic goiter. Table 1 shows the distribution of patients, sex, median age at first discharge, number of patients in each age group, number of events, number of patients censored, and number of patients who were also admitted with an abuse diagnosis. Among patients with In the initial Poisson regression analyses, three interactions were included in the model: sex and index-diagnosis, sex and age group, and index-diagnosis and time after index discharge. The covariates substance abuse and calendar time were included only as main effects in the analyses.
The three interactions were insignificant (results not shown). The main effects were all highly significant (Table 2) .
Patients with an index diagnosis of obesity had a 1.35 (95% CI: 1.09-1.67) times greater rate of affective-disorders hospitalizations when compared to patients with an index diagnosis of osteoarthritis. Patients with an index diagnosis of obesity had a 1.23 (95% CI: 0.99-1.53) times greater rate of affective-disorders hospitalizations when compared to patients with an index diagnosis of non-toxic goiter. Patients with an index diagnosis of non-toxic goiter had a 1.10 (95% CI: 0.94-1.29) times greater rate of affective disorders when compared to patients with an index diagnosis of osteoarthritis.
Women had a greater risk of hospitalization with affective disorders than men (Table 2) , and the risk of affective disorders was greatest in the age groups between 70 and 85 years (results not shown). The incidence of affective diagnoses was greatest in the calendar period from 1994 to 1999.
A diagnosis of abuse was associated with an increased risk of affective disorders (rate ratio 6.73 (95% Cl: 5.51-8.22)). Six percent of the patients who were hospitalised with a diagnosis of obesity also had at least one hospital diagnosis of abuse, and overall 3393 patients in the study sample received an additional diagnosis of abuse. To test whether the effect of the index diagnosis was mediated through a greater risk of affective disorders for patients with obesity that had an additional abuse diagnosis, the interaction between index diagnosis and abuse was added to the Poisson analyses. This interaction was significant (P ¼ 0.0007). Table 3 shows the relative rates of affective disorders for patients with the three different index diagnoses, with or without comorbid abuse. The effect of having comorbid abuse differed within the three cohorts as patients with obesity with comorbid abuse had a rate ratio of affective disorders of 3.58 (95% CI: 2.19-5.85) when compared to patients with obesity without comorbid abuse, while the rate ratio for patients with non-toxic goiter with comorbid abuse was 11.88 (95% CI: 8.08-17.45) when compared to patients with non-toxic goiter without abuse, and the rate ratio for patients with osteoarthritis with comorbid abuse was 6.79 (95% CI: 5.25-8.79) when compared to patients with osteoarthritis without abuse. Figures 1 and 2 show the estimated probabilities of a later admission with a discharge diagnosis of affective disorders Table 2 The rate ratios with 95% confidence intervals of the main effects of index diagnosis, sex, time after index discharge, calendar time, and abuse
Covariates
Rate ratio 95% CI P-value Obesity No comorbid abuse, all patients 1.00 Figure 1 Estimated probability of admission with a resulting discharge diagnosis of affective disorders for women without abuse from each of the study cohorts, hospitalized with an index diagnosis at age 50. The estimated probabilities relate to the calendar period 1 January 1994 to 31 December 1999. For both groups the rate of affective disorders among patients with osteoarthritis is set to 1.00 and rate ratios with 95% confidence intervals are presented for patients from the two other cohorts.
Obesity and affective disorders AF Thomsen et al for patients with an index hospitalization at the age of 50 years, for women without abuse and men without abuse, respectively. The probabilities are adjusted for the competing risk of death. Patients discharged with a diagnosis of obesity had an increased risk of affective-disorders hospitalization throughout their lifetime. Women had a greater risk than men, with an estimated risk of 2% over a 20-year period.
The curve for women rises with an approximately constant gradient throughout the patients' lifetime. The curve for men declines at age 65-70, probably because of increased mortality in the group of patients with obesity as index diagnosis. The same pattern of estimated probabilities was found for patients of 40, 60, 70 and 80 years of age at index discharge (figures not shown).
Discussion
This study investigated the risk of hospitalization with affective disorders for patients with hospital diagnoses of obesity relative to that of control patients. In absolute numbers, hospital admissions with affective-disorder diagnoses were infrequent events: 1081 admissions occurred among the 165 425 patients within the observational period from 1977 to 1999. This low number reflects that only patients with severe episodes of affective disorders were treated as in-hospital patients, and that less debilitating affective episodes were managed in outpatient settings. The two control cohorts -patients with osteoarthritis and patients with non-toxic goiter -did not differ significantly from each other in their risk of affective disorders. We found that patients with obesity had a small, but significant, increase of risk of affective disorders when compared to patients with osteoarthritis. Patients with obesity showed a tendency towards having a greater risk of affective disorders than patients with non-toxic goiter, but the difference was not statistically significant. The risk estimates had confidence intervals with upper limits of 1.67 and 1.53, respectively, which means that a large excess risk of affective disorders is very unlikely. Thus, from this comparison with two control groups we suggest that patients hospitalized with obesity may be prone to developing severe affective disorders, but that the excess risk is quite modest.
Previous cross-sectional studies have shown high rates of affective disorders among patients treated for obesity. Black et al. found that 31% of 88 morbidly obese patients seeking bariatric surgery had a history of mood disorder defined from DSM-III criteria, compared with 9% of 76 normal weight control persons. In all, 4.5% of the patients with obesity had a history of bipolar disorder, compared with 0% of the control persons. Britz et al. found that the lifetime prevalence of DSM-IV defined mood disorders among 47 young in-patients treated for extreme obesity was 43%, compared with 17% among 47 obese non-patients and 15% among control persons from the general population.
The prospective risk of the specific outcome event 'hospitalization with an affective disorder' has not been investigated for patients with obesity before, but considering the retrospective studies of lifetime prevalence of mood disturbances it is somewhat surprising that hospitalizations with affective disorders were not more common in the cohort of patients with obesity. The present study does not exclude an increased prevalence of mood symptoms among patients with obesity, as a tendency towards more hospitalizations with affective disorders is likely to reflect a greater incidence of affective disorder episodes that do not lead to hospital admission, and probably also a greater incidence of subclinical mood disturbances, in the cohort of patients with obesity. However, seemingly the long-term risk of severe affective disorders that cannot be managed in outpatient settings is not greatly increased among severely obese patients.
The choice of control groups is important when interpreting these results. Whereas it is difficult to find control diseases that are precisely comparable with obesity with regard to social and health disadvantages, patients with obesity were compared to patients with chronic diseases in order to correct for the unspecified effects on mood regulation of having an ongoing physical disorder. We chose control persons with diseases where the underlying pathology, or the treatment of the disease, is not known to increase the risk of affective disorders. By using data from nationwide registers, and by comparing patients discharged from hospital with diagnoses of obesity with patients who passed the thresholds of hospital admission with other chronic conditions, we avoided recall bias, Berksons bias, and selection bias owing to non-participation, or to geographic or socioeconomic factors.
Osteoarthritis, like obesity, may result in physical discomfort and inactivity, and may pose long-term psychological concerns for patients. 24 Influence of mood regulation or other major brain functions has not been associated with Figure 2 Estimated probability of admission with a resulting discharge diagnosis of affective disorders for men without abuse from each of the study cohorts, hospitalized with an index diagnosis at age 50. The estimated probabilities relate to the calendar period 1 January 1994 to 31 December 1999.
Obesity and affective disorders AF Thomsen et al osteoarthritis. 25, 26 As expected, the age distribution of the osteoarthritis cohort was different from that of the obesity cohort, but because the osteoarthritis cohort included an ample number of patients within the same ranges of age as the patients with obesity (Table 1) , it was possible to correct for this difference in the Poisson regression analyses. Thus, the analyses compare patients with obesity within a given age group and with a given sex with control patients of similar age and sex. Osteoarthritis is associated with increased patient BMI, 27 so using patients with osteoarthritis as the only control group to patients with obesity diagnoses could lead to an underestimation of the risk of affective disorders relative to the general population. To address this problem, we included patients with non-toxic goiter as an additional control group. Goiter patients have previously been used as control patients in comparative studies of mental functioning of patients with other endocrine disorders, 28 and although non-toxic goiter, like obesity, is associated with low socioeconomic status, 29 non-toxic goiter is not known to directly influence mood regulation or brain function. A recent study suggests that subtle, and subclinical, disturbances in thyroid function may be associated with weight gain, 30 and nontoxic goiter may thus also be associated with obesity. The fact that the patients from the two control groups did not have a significantly different risk of affective disorders increases our confidence in the validity of the marginally higher rates of affective disorders found among patients hospitalized with obesity. However, because both patients with osteoarthritis and patients with non-toxic goiter may be at increased risk of obesity, these rates may represent an underestimation of the risk of affective disorder of patients with obesity relative to persons who are truly unexposed to the effects of obesity.
Cross-sectional population studies of mental disorders associated with obesity suggest that obese women have increased rates of depressive symptoms whereas obese men do not. [31] [32] [33] In our analyses, the interaction between sex and index diagnosis was not significant. This means that women had a greater risk of affective disorders than men, regardless of the index diagnosis, and that the effect of sex was the same among patients with obesity and among the control patients. The combination of being a woman and having an index diagnosis of obesity did not enhance the risk of affective disorders, and the combination of being a man and having an index diagnosis of obesity did not reduce the risk of affective disorders.
Substance use was prevalent in the cohort of patients with diagnoses of obesity as 6.0% of these patients at some time received an additional diagnosis of abuse. Overall, comorbid abuse was associated with a 6.73 (95% CI: 5.25-8.79) times greater risk of subsequent affective disorders. However, when comparing patients with comorbid abuse to patients without comorbid abuse within the obesity cohort, the risk was only 3.58 (95% CI: 2.19-5.85). The increased risk of affective disorders among patients with non-toxic goiter and comorbid abuse is surprising, as presence of goiter is inversely related to alcohol consumption, 34 and patients with severe alcohol abuse, who are also at high risk of affective disorders, would be expected to be under-represented in this cohort. The result may be relevant in further studies of thyroid disease. In the present context, the important point is that patients with obesity who had comorbid abuse were at decreased risk of affective disorders compared to patients with non-toxic goiter with comorbid abuse, and at similar risk as patients with osteoarthritis with comorbid abuse. So while the increased prevalence of abuse among the patients with obesity in itself put these patients at higher risks of affective disorders, comorbid abuse was a less pronounced risk factor for patients with obesity than it was for patients from the other cohorts.
Patients with obesity without an additional hospital diagnosis of abuse had a risk of affective disorders that was 1.55 (95% CI: 1.23-1.95) times greater than the risk of the osteoarthritis patients without abuse. This suggests that severe obesity is associated with other risk factors than those related to comorbid alcohol-or substance abuse or to abuserelated behaviour.
There are diverse links between mood disorders and obesity. Speculatively, genetic predisposition, low socioeconomic status, comorbid binge-eating disorder, dieting, physical inactivity, social stigmatization, and general ill health could all be factors mediating a modestly increased long-term risk of affective disorder hospitalizations among patients with obesity. [35] [36] [37] Further prospective studies of the factors influencing the mood regulation of morbidly obese individuals are warranted.
